Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 27 (NPM1P27)

Target
NPM1P27
Molecular classification
Other (Pseudogene)
01

Overview

Nucleophosmin 1 pseudogene 27 (NPM1P27) is a non-functional, non-protein-coding DNA sequence that represents a pseudogene of the NPM1 gene. Unlike the canonical NPM1 gene, which encodes a nucleolar phosphoprotein implicated in processes such as ribosomal biogenesis and is frequently mutated in acute myeloid leukemia (AML)[2], NPM1P27 does not encode a protein or participate in recognized biological or pathogenic pathways. There is no evidence linking NPM1P27 to therapeutic drug targeting, disease mechanisms, or biomarker use. Pseudogenes are generally not considered legitimate molecular targets in drug discovery or disease diagnostics unless specific evidence demonstrates a functional or regulatory role, which does not apply to NPM1P27. This entry has been included in error as a putative target: it is neither a receptor, enzyme, nor any molecule with established clinical significance. The canonical NPM1 gene, by contrast, is an important molecular target and biomarker in hematologic malignancies, but the pseudogene (NPM1P27) is not[2]. If you intended the functional nucleophosmin 1 (NPM1) gene or protein, or another related molecule, please clarify, as only the canonical NPM1 (not any NPM1 pseudogene) is established as a therapeutic target[2].

Other names
NPM1 pseudogene 27
02

Mechanism of action

None

03

Biological functions

None established; pseudogenes typically do not have protein-coding functions
04

Disease associations

None known; no established disease association

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 27 (NPM1P27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 27 (NPM1P27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call